DUBLIN, June 7, 2023 /PRNewswire/ — The “Optogenetics Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the market.
The global optogenetics market is expected to grow from $28.15 billion in 2022 to $32.26 billion in 2023 at a compound annual growth rate (CAGR) of 14.6%. The optogenetics market is expected to grow to $54.24 billion in 2027 at a CAGR of 13.9%.
Major players in the optogenetics market are Elliot Scientific Ltd., Shanghai Laser & Optics Century Co. Ltd., GenSight Biologics, Danaher Corporation, Coherent Inc., Thorlabs Inc., Prizmatix Ltd., Bruker Corporation, Judges Scientific Plc., Merck KGaA, The Jackson Laboratory, Noldus Information Technology BV, Applied Genetic Technologies Corporation, Circuit Therapeutics Inc., Bionic Sight LLC, Teledyne Photometrics, Campden Instruments, and Nanoscope Therapeutics Inc.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Optogenetics is a comprehensive technique that uses optical systems and genetic engineering technologies to accurately regulate and monitor the biological processes of a cell, group of cells, tissues, or organ with high temporal and spatial resolution. Optogenetics is to monitor and control the physiological activity of neurons and other cell types that include light sensors frequently employed to identify the underlying causes of ailments like Parkinson’s, memory illnesses, anxiety, addiction issues, mood swings, and other conditions.
The main products of optogenetics include lasers, actuators and sensors. Laser refers to a device that emits light through a process of optical amplification at particular wavelengths producing a very narrow beam of light. Their various applications include neuroscience, behavioral tracking, retinal disease treatment and others for use by end-users such as hospitals and clinics, diagnostics centers, research centers and others.
The development of innovative systems is the key trend gaining popularity in the optogenetics market. Major companies operating in the optogenetics market are developing innovative optogenetics tools and systems with cutting-edge technologies to sustain their position in the market.
For instance, in June 2022, Bruker Corporation, a US-based optogenetics tool manufacturer company launched NeuraLight 3D Ultra, an enhanced 3D holographic stimulation for optogenetics module to support advanced neuroscience and optogenetics research applications on Bruker’s Ultima 2Pplus Multiphoton Microscope. NeuraLight 3D Ultra offers cutting-edge 3D holographic photostimulation tailored for in-depth functional research on neural networks and brain computation.
In September 2021, Novartis AG, a Switzerland-based pharmaceutical corporation acquired Arctos Medical AG for an undisclosed amount. This acquisition aims to increase Novartis’ presence in ophthalmology and strengthen its position in AAV-based gene therapy and provide patients with severe vision loss with novel treatments. Arctos Medical is a Switzerland-based gene therapy start-up company specializing in optogenetics therapies.
North America was the largest region in the optogenetics market in 2022. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the optogenetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The rising cases of Parkinson’s disease and epilepsy across the world are expected to propel the growth of the optogenetics market going forward. Parkinson’s disease (PD) is defined as a degenerative condition of the brain that causes motor symptoms like slow movement tremors, rigidity, and imbalance in addition to other problems like cognitive decline, mental health issues, sleep issues, pain, and sensory disturbances.
Epilepsy is a brain condition that results in seizures. In optogenetic therapy, proteins that respond to specific wavelengths of light are used to treat Parkinson’s disease. These proteins can be produced using gene therapy techniques to either activate or inactivate when exposed to specific types of light, ultimately leading to the normalization of brain function in Parkinson’s disease (PD).
The optogenetics market consists of sales of optical cannula, fiber-optic cable, and light sources. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Key Topics Covered:
1. Executive Summary
2. Optogenetics Market Characteristics
3. Optogenetics Market Trends And Strategies
4. Optogenetics Market – Macro Economic Scenario
4.1. COVID-19 Impact On Optogenetics Market
4.2. Ukraine-Russia War Impact On Optogenetics Market
4.3. Impact Of High Inflation On Optogenetics Market
5. Optogenetics Market Size And Growth
5.1. Global Optogenetics Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Optogenetics Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Optogenetics Market Segmentation
6.1. Global Optogenetics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
6.2. Global Optogenetics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Neuroscience
- Behavioral Tracking
- Retinal Disease Treatment
- Other Applications
6.3. Global Optogenetics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Hospitals And Clinics
- Diagnostics Centres
- Research Centres
- Other End Users
7. Optogenetics Market Regional And Country Analysis
7.1. Global Optogenetics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Optogenetics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/8uetbz
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
